Contrast Medium-Induced Nephropathy

  • Henrik S. Thomsen
  • Fulvio Stacul
  • Judith A. W. Webb
Part of the Medical Radiology book series (MEDRAD)


A sudden drop in renal function after exposure to contrast media was first described more than 60 years ago. Contrast medium-induced nephropathy (CIN) is still considered an important acute adverse reaction. Despite both clinical and experimental research, its pathophysiology is still unclear. It occurs to the same extent after all non-ionic iodine-based contrast agents. Patients at increased risk are those with moderately and severely reduced renal function. Volume expansion seems to reduce the frequency, but no pharmacological manipulation has been proven to be helpful. This chapter reviews the recent information on CIN.


Chronic Kidney Disease Contrast Medium Kidney Disease Improve Global Outcome Contrast Medium Administration Nephrotoxic Potential 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Alamartine E, Phayphet M, Thibaudin D et al (2003) Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations. Eur J Intern Med 14:426–431PubMedGoogle Scholar
  2. Allaqaband S, Tumuluri R, Malik AM et al (2002) Prospective randomized study of N-acetylcysteine, fenoldopam and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Intervent 57:279–283Google Scholar
  3. Almen T, Frennby B, Sterner G (1999) Determination of glomerular filtration rate (GFR) with contrast media. In: Thomsen HS, Muller RN, Mattrey RF (eds) Trends in contrast media. Springer, Berlin, pp 81–94Google Scholar
  4. Alonso A, Lau J, Jaber BL et al (2004) Prevention of contrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized controlled trials. Am J Kidney Dis 43:1–9PubMedGoogle Scholar
  5. Andrew E, Berg KJ (2004) Nephrotoxic effects of X-ray contrast media. J Toxicol Clin Toxicol 42:325–332PubMedGoogle Scholar
  6. Asif A, Epstein M (2004) Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 44:12–24PubMedGoogle Scholar
  7. Aspelin P, Aubry P, Fransson S-G et al (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491–499PubMedGoogle Scholar
  8. Bader BD, Berger ED, Heede MB et al (2004) What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol 62:1–7PubMedGoogle Scholar
  9. Bagshaw SM, Ghali WA (2004) Acetylcysteine for prevention of contrast induced nephropathy after intravascular angiography: a systematic review and meta-analysis. BMC Med 2:38PubMedPubMedCentralGoogle Scholar
  10. Bagshaw SM, Ghali WM (2005) Theophylline for prevention of radiocontrast nephropathy: a systematic review and meta-analysis. Arch Intern Med 176:1087–1093Google Scholar
  11. Bagshaw SM, McAlister FA, Manns BJ, Gahli WA (2006) Acetylcysteine in the prevention of contrast-induced nephropathy. Arch Intern Med 166:161–166PubMedGoogle Scholar
  12. Bailey CJ, Turner RC (1996) Metformin. New Engl J Med 334:574–579PubMedGoogle Scholar
  13. Balemans CE, Reichert IJ, van Scheven BI et al (2012) Epidemiology of contrast material induced nephropathy in the era of hydration. Radiology 263:706–713PubMedGoogle Scholar
  14. Band RA, Gaieski DF, Mills AM et al (2007) Discordance between serum creatinine and creatinine clearance for identification of ED patients with abdominal pain at risk for contrast induced nephropathy. Am J Emerg Med 25:268–272PubMedGoogle Scholar
  15. Barrett BJ, Parfrey PS (2006) Preventing nephropathy induced by contrast medium. N Engl J Med 354:379–386PubMedGoogle Scholar
  16. Barrett BJ, Katzberg RW, Thomsen HS et al (2006) Contrast induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double blind comparison of iodixanol and iopamidol. Invest Radiol 41:815–821PubMedGoogle Scholar
  17. Bartels ED, Brun GC, Gammeltoft A, Gjørup PA (1954) Acute anuria following intravenous pyelography in a patient with myelomatosis. Acta Med Scand 40:297–302Google Scholar
  18. Bartholomew BA, Harjai KJ, Dukkipati S et al (2004) Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93:1515–1519PubMedGoogle Scholar
  19. Becker J, Babb J, Serrano M (2013) Glomerular filtration rate in evaluation of the effect of iodinated contrast media on renal function. AJR Am J Roentgenol 200:822–826PubMedGoogle Scholar
  20. Benigni A, Remuzzi G (1999) Endothelin antagonists. Lancet 353:133–138PubMedGoogle Scholar
  21. Berns AS (1989) Nephrotoxicity of contrast media. Kidney Int 36:730–740PubMedGoogle Scholar
  22. Bellomo R, Ronco C, Kellum JA et al (2004) Acute dialysis quality initiative workgroup: acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs. the second international consensus conferences of the acute dialysis quality initiative (ADQI) group. Crit Care 8:R204–R212PubMedGoogle Scholar
  23. Bettmann MA (2005) Contrast medium-induced nephropathy: critical review of the existing clinical evidence. Nephrol Dial Transplant 20(Suppl 1):i12–i17PubMedGoogle Scholar
  24. Biondi-Zoccai GG, Lotrionte M, Abbate A et al (2006) Compliance with QUOROM and quality of reporting over overlapping meta-analysis on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study. Br Med J 332:202–209Google Scholar
  25. Blaufox MD, Aurell M, Bubeck B et al (1996) Report of the radionuclide in nephrourology committee on renal clearance. J Nucl Med 37:1883–1890PubMedGoogle Scholar
  26. Bolen S, Feldman L, Vassy J et al (2007) Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 147:386–399PubMedGoogle Scholar
  27. Bostrom AG, Kronenberg F, Ritz E (2002) Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 13:2140–2144Google Scholar
  28. Botev R, Mallie P, Wetzels J, Couch C (2011) The clinician and estimated glomerular filtration rate. Clin J Am Soc Nephrol 6:937–950PubMedGoogle Scholar
  29. Brar SS, Hiremath S, Dangas G et al (2009) Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol 4:1584–1592PubMedGoogle Scholar
  30. Briguori C, Colombo A, Airoldi F et al (2004a) N-acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity. J Am Coll Cardiol 44:762–765PubMedGoogle Scholar
  31. Briguori C, Colombo A, Violante A et al (2004b) Standard versus double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 25:206–211PubMedGoogle Scholar
  32. Briguori C, Colombo A, Airoldi F et al (2006) Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine. Kidney Int 68:2250–2255Google Scholar
  33. Briguori C, Airoldi F, D’Andrea D et al (2007) Renal insufficiency following contrast media administration trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 115:1211–1217PubMedGoogle Scholar
  34. Carraro M, Mancini W, Artero M et al (1996) Dose effect of nitrendipine on urinary enzymes and microproteins following nonionic radiocontrast administration. Nephrol Dial Transplant 11:444–448PubMedGoogle Scholar
  35. Carraro M, Malalan F, Antonione R et al (1998) Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate insufficiency: a double blind, randomized trial. Eur Radiol 8:144–147PubMedGoogle Scholar
  36. Cavusoglu E, Chabra S, Marmur JD et al (2004) The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Minerva Cardioangio 52:419–432Google Scholar
  37. Chalmers N, Jackson RW (1999) Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 72:701–703PubMedGoogle Scholar
  38. Chen Y, Hu S, Liu Y et al (2012) Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study. EuroIntervention 8:830–838PubMedGoogle Scholar
  39. Chertow GM, Burdich E, Honour M et al (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16:3365–3370Google Scholar
  40. Cheruvu B, Henning K, Mulligan J et al (2007) Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations. J Comput Assist Tomogr 31:493–498PubMedGoogle Scholar
  41. Choyke PL, Cady K, DePollar SL, Austin H (1998) Determination of serum creatinine prior to iodinated contrast media: is it needed in all patients? Tech Urol 4:65–69PubMedGoogle Scholar
  42. Chuang F-R, Chen T-C, Wang I-K (2009) Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study. Ren Fail 31:181–188PubMedGoogle Scholar
  43. Clavijo LC, Pinto TL, Kuchulakanti PK et al (2006) Effect of a rapid intraarterial infusion of dextrose 5 % prior to coronary angiography on frequency of contrast-induced nephropathy in high-risk patients. Am J Cardiol 97:981–983PubMedGoogle Scholar
  44. Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41Google Scholar
  45. Couchoud C, Pozet N, Labeeuw M, Pouteil-Noble C (1999) Screening early renal failure: cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int 55:1878–1884PubMedGoogle Scholar
  46. Cramer BC, Parfrey PS, Hutchinson TA et al (1985) Renal function following infusion of radiologic contrast material: a prospective controlled study. Arch Intern Med 145:87–89PubMedGoogle Scholar
  47. Cryer DR, Nicholas SP, Henry DH et al (2005) Comparative outcomes study of metformin intervention versus conventional approach: the COSMIC approach study. Diabetes Care 28:539–543PubMedGoogle Scholar
  48. Curham GC (2003) Prevention of contrast nephropathy. JAMA 289:606–608Google Scholar
  49. Dai B, Liu Y, Fu L et al (2012) Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials. Am J Kidney Dis 60:360–370PubMedGoogle Scholar
  50. Davenport MS, Khalatbari S, Dillamn JR et al (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology 267:94–105PubMedGoogle Scholar
  51. Davidson CJ, Hlatky M, Morrris KG et al (1989) Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 110:119–124PubMedGoogle Scholar
  52. Dittrich E, Puttinger H, Schillinger M (2006) Effect of radio contrast media on residual function in peritoneal dialysis patients—a prospective study. Nephrol Dial Transplant 21:1334–1339PubMedGoogle Scholar
  53. Dussol B, Morange S, Loundoun A et al (2006) A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. Nephrol Dial Transplant 21:2120–2126PubMedGoogle Scholar
  54. Eken C, Kilicaslan I (2007) Differences between various glomerular filtration rate calculation methods in predicting patients at risk for contrast-induced nephropathy. Am J Emerg Med 25:487 (Correspondence)Google Scholar
  55. Electronic Medicines Compendium (2012a) Updated 12-10-10. Accessed 17 Dec 12
  56. Electronic Medicines Compendium (2012b) Updated 23-5-12. Accessed 17 Dec 12
  57. Erdogan A, Davidson CJ (2003) Recent clinical trials of iodixanol. Rev Cardiovasc Med 4(Suppl 5):S43–S50PubMedGoogle Scholar
  58. Erley CM, Duda SH, Rehfuss D et al (1999) Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant 14:1146–1149PubMedGoogle Scholar
  59. Fishbane S, Durham JH, Marzo K, Rudnick M (2004) N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 15:251–260PubMedGoogle Scholar
  60. Fishman EK, Reddan D (2008) What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography. Acta Radiol 49:310–320PubMedGoogle Scholar
  61. Fliser D, Laville M, Covic A et al (2012) A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 27:4263–4273PubMedGoogle Scholar
  62. From AM, Bartholmai BJ, Williams AW et al (2008) Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc 83:1095–1100PubMedGoogle Scholar
  63. Fu N, Lia X, Yang S et al (2013) Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention. Angiology 64:188–194PubMedGoogle Scholar
  64. Gare M, Haviv YS, Ben-Yehuda A et al (1999) The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol 34:1682–1688PubMedGoogle Scholar
  65. Gleeson T, Bulugahapitiya S (2004) Contrast induced nephropathy. Am J Roentgenol 183:1673–1689Google Scholar
  66. Goergen SK, Rumbold G, Compton G, Harris C (2010) Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin. Radiology 254:261–269PubMedGoogle Scholar
  67. Goldenberg I, Matezky S (2005) Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 172:1461–1467PubMedPubMedCentralGoogle Scholar
  68. Gomes VO, Lasevitch R, Lima VC et al (2012) Hydration with sodium bicarbonate does not prevent contrast nephropathy: a multicenter clinical trial. Arq Bras Cardiol 99:1129–1134PubMedGoogle Scholar
  69. Gruberg L, Mintz GS, Mehran R et al (2000) The prognostic implications of further renal function deterioration with 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36:1542–1548PubMedGoogle Scholar
  70. Gupta RK, Kapoor A, Tewari S et al (1999) Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study. Indian Heart J 51:521–536PubMedGoogle Scholar
  71. Hans SS, Hans BA, Dhillon R et al (1998) Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency. Am Surg 64:432–436PubMedGoogle Scholar
  72. Hardiek KJ, Katholi RE, Robbs RS, Katholi CE (2008) Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography. J Diabetes Complications 22:171–177PubMedGoogle Scholar
  73. Haylor JL, Morcos SK (2000) Endothelin antagonism and contrast nephropathy. Kidney Int 58:2239PubMedGoogle Scholar
  74. Heinrich MC, Häberle L, Müller V et al (2009) Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analyses of randomized controlled trials. Radiology 250:68–86PubMedGoogle Scholar
  75. Heinrich MC, Kuhlmann MK, Grgic A et al (2005) Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology 235:843–849PubMedGoogle Scholar
  76. Heller CA, Knapp J, Halliday et al (1991) Failure to demonstrate contrast nephrotoxicity. Med J Aust 155:329–332Google Scholar
  77. Heyman SN, Rosenberger C, Rosen S (2005) Regional alterations in renal haemodynamics and oxygenation: a role contrast medium-induced nephropathy. Nephrol Dial Transplant 20(Suppl 1):i6–i11PubMedGoogle Scholar
  78. Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analysis. Br Med J 327:557–560Google Scholar
  79. Hoffmann U, Fischereder M, Kruger B et al (2004) The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15:407–410PubMedGoogle Scholar
  80. Hogan SE, L'Allier P, Chetcuti S et al (2008) Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. Am Heart J 156:414–421PubMedGoogle Scholar
  81. Holstein A, Stumvoll M (2005) Contraindications can damage your health- is metformin a case in point? Diabetologia 48:2454–2459PubMedGoogle Scholar
  82. Hoste EAJ, Doom S, De Waele J et al (2011) Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med 37:1921–1931PubMedGoogle Scholar
  83. Hou SH, Bushinsky DA, Wish JB et al (1983) Hospital acquired renal insufficiency: a prospective study. Am J Med 74:243–248PubMedGoogle Scholar
  84. Huber W, Ilgman K, Page M et al (2002) Effect of theophylline on contrast material-induced nephropathy on patients with chronic renal insufficiency: controlled, randomized, double-blinded study. Radiology 223:772–779PubMedGoogle Scholar
  85. Ix JH, McCullough CE, Chertow GM (2004) Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. Nephrol Dial Transplant 19:2747–2753PubMedGoogle Scholar
  86. Jabara R, Gadesam RR, Pendyla LK (2009) Impact of the definition utilizes on the rate of contrast-induced nephropathy in percutaneous coronary intervention. Am J Cardiol 103:1657–1662PubMedGoogle Scholar
  87. Jakobsen JA, Lundby B, Kristoffersen DT et al (1992) Evaluation of renal function with delayed CT after injection of non- ionic monomeric and dimeric contrast media in healthy volunteers. Radiology 182:419–424PubMedGoogle Scholar
  88. James MT, Ghali WA, Knudtson ML et al (2011) Alberta Provencial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation 123:409–416PubMedGoogle Scholar
  89. Jingwei N, Ruiyan Z, Jiansheng Z et al (2006) Safety of isoosmolar dimer during percutaneous coronary intervention. J Interv Radiol 15:327–329Google Scholar
  90. Jo S-H, Youn T-J, Koo B-K et al (2006) Renal toxicity evaluation and comparison betweenVisipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography. The RECOVER study: a randomized controlled trial. J Am Coll Cardiol 48:924–930PubMedGoogle Scholar
  91. Joannidis M, Schmid M, Wiedermann CJ (2008) Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis. Wien Klin Wochenschr 120:742–748PubMedGoogle Scholar
  92. Katzberg RW (1997) Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 204:297–312PubMedGoogle Scholar
  93. Katzberg R (2005) Contrast medium-induced nephrotoxicity: which pathways? Radiology 235:752–755PubMedGoogle Scholar
  94. Katzberg R, Barrett B (2007) Risk of contrast-induced nephropathy with intravenous administration of iodinated contrast media. Radiology 243:622–628PubMedGoogle Scholar
  95. Kidney Disease: Improving Global Outcomes (KDIGO) (2013) CKD Work Group. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150Google Scholar
  96. Kini AS, Mitre CA, Kim M et al (2002) A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam. Catheter Cardiovasc Interv 55:169–173PubMedGoogle Scholar
  97. Kim KS, Kim K, Hwang SS et al (2011) Risk stratification nomogram for nephropathy after abdominal contrast-enhanced computed tomography. Am J Emerg Med 29:412–417PubMedGoogle Scholar
  98. Kim IY, Lee SB, Lee DW et al (2012) Long-term effects of radiocontrast-enhanced computed tomography on the renal function of chronic kidney disease patients. Clin Exp Nephrol 16:755–759PubMedGoogle Scholar
  99. Kolehmainen H, Soiva M (2003) Comparison of Xenetix 300 and Visispaque 320 in patients with renal failure. Eur Radiol 13:B32–B33Google Scholar
  100. Krasuski RA, Beard BM, Geoghagan JD et al (2003) Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study. J Invasive Cardiol 15:699–702PubMedGoogle Scholar
  101. Kshirsagar AV, Poole C, Mottl A et al (2004) N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a metaanalysis of prospective controlled trials. J Am Soc Nephrol 15:761–769PubMedGoogle Scholar
  102. Kuhn MJ, Chen N, Sahani DV et al (2008) The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. Am J Roentgenol 1991:151–157Google Scholar
  103. LaBounty TM, Shah M, Raman SV et al (2012) Within-hospital and 30-day outcomes in 107,994 patients undergoing invasive coronary angiography with different low-osmolar iodinated contrast media. Am J Cardiol 109:1594–1599PubMedGoogle Scholar
  104. Lameire NH (1997) The impact of residual renal function on the adequacy of peritoneal dialysis. Nephron 77:13–28PubMedGoogle Scholar
  105. Laskey W, Aspelin P, Davidson C et al (2009) Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures. Am Heart J 158:822–828PubMedGoogle Scholar
  106. Ledermann HP, Mengiardi B, Schmid A, Froehlich JM (2010) Screening for renal insufficiency following ESUR guidelines with on-site creatinine measurements in an outpatient setting. Eur Radiol 20:1926–1933PubMedGoogle Scholar
  107. Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461–470PubMedGoogle Scholar
  108. Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612PubMedPubMedCentralGoogle Scholar
  109. Liu R, Nair D, Ix J et al (2005) N-acetylcysteine and contrast- induced nephropathy: systematic review and metaanalysis. J Gen Intern Med 20:193–200PubMedPubMedCentralGoogle Scholar
  110. Love L, Johnson MS, Bresler ME et al (1994) The persistent computed tomography nephrogram: its significance in the diagnosis of contrast-associated nephrotoxicity. Br J Radiol 67:951–957PubMedGoogle Scholar
  111. Maeder M, Klein M, Fehr T, Rickli H (2004) Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 44:1763–1771PubMedGoogle Scholar
  112. Marenzi G, Lauri G, Assanelli E et al (2004) Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44:1780–1785PubMedGoogle Scholar
  113. Marenzi G, Assanelli E, Marana I et al (2006) N-acetylcysteine and contrast-induced nephropathy in primay angioplasty. N Engl J Med 354:273–278Google Scholar
  114. Marenzi G, Ferrari C, Marana I et al (2012) Prevention of contrast nephropathy by furosemide with matched hydration. The MYTHOS (induced diuresis with matched hydration compared to standard hydration for contrast induced nephropathy prevention) Trial. JACC Cardiovasc Interv 5:90–97PubMedGoogle Scholar
  115. McCarthy CS, Becker JA (1992) Multiple myeloma and contrast media. Radiology 183:519–521PubMedGoogle Scholar
  116. McCullough PA, Bertrand ME, Brinker JA, Stacul F (2006a) A meta-analysis of the renal safety of iso-osmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 48:692–699PubMedGoogle Scholar
  117. McCullough PA, Sandberg KR (2003) Epidemiology of contrast induced nephropathy. Rev Cardiovasc Med 4:53–59Google Scholar
  118. McCullough PA, Stacul F, Becker CR et al (2006b) Contrast-Induced Nephropathy (CIN) consensus working panel: executive summary. Rev Cardiovasc Med 7(4):177–197PubMedGoogle Scholar
  119. McCullough PA, Wolyn R, Rocher LL et al (1997) Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med 103:368–375PubMedGoogle Scholar
  120. McDonald JS, McDonald RJ, Comin J et al (2013a) Frequency of acute kidney injury following intravenous contrast administration: a systemic review and meta-analysis. Radiology 267:119–128PubMedGoogle Scholar
  121. McDonald RJ, McDonald JS, Bida JP et al (2013b) Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 267:106–118PubMedGoogle Scholar
  122. Mehran R, Aymong ED, Nikolsky E et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. Development and initial validation. J Am Coll Cardiol 44:1393–1399PubMedGoogle Scholar
  123. Mehran R, Nikolsky E, Kirtane AJ et al (2009) Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. JACC Cardiovasc Interv 2:415–421PubMedGoogle Scholar
  124. Mehta RL, Kellum JA, Shah SV et al (2007) Acute kidney injury network. Acute kidney network; report of an initiative to improved outcomes in acute kidney injury. Crit Care 121:R31Google Scholar
  125. Meier P, Ko DT, Tamura A et al (2009) Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis. BMC Med 7:23PubMedPubMedCentralGoogle Scholar
  126. Merten GJ, Burgess WP, Gray LV et al (2004) Prevention of contrast induced nephropathy with sodium bicarbonate: a randomized trial. JAMA 291:2328–2338PubMedGoogle Scholar
  127. Meschi M, Detrenis S, Musini S et al (2006) Facts and fallacies concerning the prevention of contrast medium induced nephropathy. Crit Care Med 34:2060–2068PubMedGoogle Scholar
  128. Mitchell RL, Craig JC, Webster AC (2004) Cochrane renal group report. Am J Kidney Dis 43:752–756Google Scholar
  129. Michels WM, Grootendorst DC, Verduijn M et al (2010) Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 5:1003–1009PubMedGoogle Scholar
  130. Molitoris BA, Levin A, Warnock DG et al (2007) Improving outcomes of acute kidney injury: report of an initiative. Nat Clin Pract Nephrol 3:439–442PubMedGoogle Scholar
  131. Morcos SK (1998) Contrast media-induced nephrotoxicity—questions and answers. Br J Radiol 71:357–365PubMedGoogle Scholar
  132. Morcos SK (2004) Prevention of contrast media nephrotoxicity—the story so far. Clin Radiol 59:381–389PubMedGoogle Scholar
  133. Morcos SK (2005) Prevention of contrast media-induced nephrotoxicity after angiographic procedures. J Vasc Interv Radiol 16:13–23PubMedGoogle Scholar
  134. Morcos SK, Thomsen HS, Webb JAW and members of contrast media safety committee of the European Society of Urogenital Radiology (ESUR) (1999) Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 9:1602–1613Google Scholar
  135. Mueller C, Burkle G, Buerkle HJ et al (2002) Prevention of contrast media-associated nephropathy. Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329–336PubMedGoogle Scholar
  136. Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39:930–936PubMedGoogle Scholar
  137. Navaneethan SD, Singh S, Appasamy S et al (2009) Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis 53:617–627PubMedGoogle Scholar
  138. Naughton CA (2008) Drug-induced nephrotoxicity. Am Fam Physician 78:743–750PubMedGoogle Scholar
  139. Neumayer HH, Junge W, Kufner A, Wenning A (1989) Prevention of radiocontrast-media-induced nephrotoxicity by calcium channel blocker nitrendipine: a prospective randomized clinical trial. Nephrol Dial Transplant 4:1030–1036PubMedGoogle Scholar
  140. Newhouse JH, Do Kho, Rao QA, Starren J (2008) Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 191:376–382PubMedGoogle Scholar
  141. Nguyen SA, Suranyi P, Ravenel JG et al (2008) Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology 248:97–105PubMedGoogle Scholar
  142. NICE Clinical Guideline CG 87 (2009) Type 2 Diabetes—The management of type 2 diabetes. Updated March 2010. Accessed 17 Dec 12
  143. Nicholson T, Downes M (2003) Contrast nephrotoxicity and iso-osmolar contrast agents; implications of NEPHRIC. Clin Radiol 58:659–660PubMedGoogle Scholar
  144. Nikolsky E, Mehran R (2003) Understanding the consequences of contrast-induced nephropathy. Rev Cardovasc Med 4(Suppl 5):S10–S18Google Scholar
  145. Oldroyd SD, Haylor JL, Morcos SK (1995) Bosentan, an orally active endothelin antagonist: effect on the renal response to contrast media. Radiology 196:661–665PubMedGoogle Scholar
  146. Oldroyd SD, Fang L, Haylor JL et al (2000) Effects of adenosine receptor antagonists on the responses to contrast media in the isolated rat kidney. Clin Sci 98:303–311PubMedGoogle Scholar
  147. Olsen JC, Salomon B (1996) Utility of the creatinine prior to intravenous contrast studies in the emergency department. J Emerg Med 14:543–546PubMedGoogle Scholar
  148. O’Sullivan S, Healy DA, Molony MC et al (2013) The role of N-acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis. Angiology doi: 10.1177/0003319712467223
  149. Pahade JK, LeBedis CA, Raptopoulos VD et al (2011) Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT. AJR Am J Roentgenol 196:1094–1101PubMedGoogle Scholar
  150. Pannu N, Manns B, Lee H, Tonelli M (2004) Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 65:1366–1374PubMedGoogle Scholar
  151. Pannu N, Nadim MK (2008) An overview of drug-induced acute kidney injury. Crit Care Med 36(4 Suppl):S216–S223PubMedGoogle Scholar
  152. Pannu N, Wiebe N, Tonelli M for the Alberta Kidney Disease Network (2006) Prophylaxis strategies for contrast-induced nephropathy. JAMA 295:2765–2779Google Scholar
  153. Parfrey PS, Griffiths SM, Barrett BJ et al (1989) Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency or both. New Engl J Med 320:143–149PubMedGoogle Scholar
  154. Poletti PA, Saudan P, Platon A et al (2007) I.V. N-acetylcysteine and emergency CT: use of serum creatinine and Cystatin C as markers of radiocontrast nephrotoxicity. Am J Roentgenol 189:687–692Google Scholar
  155. Pugh ND, Sissons GR, Ruttley et al (1993) Iodixanol in femoral arteriography (phase III): a comparative double double-blind parallel trial between iodixanol and iopromide. Clin Radiol 47:96–99Google Scholar
  156. Recio-Mayoral A, Chaparro M, Pardo B et al (2007) The reno- protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO study. J Am Coll Cardiol 49:1238–1283Google Scholar
  157. Reddan D, Fishman EK (2008) Radiologists’ knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists. Eur J Radiol 66:235–245PubMedGoogle Scholar
  158. Reddan D, Laville M, Garovic VD (2009) Contrast-induced nephropathy and its prevention: what do we really know from evidence-based findings? J Nephrol 22:333–351PubMedGoogle Scholar
  159. Rudnick MR, Goldfarb S, Wexler L et al (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 47:254–261Google Scholar
  160. Sadeghi HM, Stone GW, Grines CL et al (2003) Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108:2769–2775PubMedGoogle Scholar
  161. Safirstein R, Andrade L, Viera JM (2000) Acetylcysteine and nephrotoxic effects of radiographic contrast agents—a new use for an old drug. N Engl J Med 342:210–211Google Scholar
  162. Salpeter S, Greyber E, Pasterank G, Salpeter EE (2010) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 25(1):CD 002967Google Scholar
  163. Sambol NC, Chiang J, Lin ET et al (1995) Kidney function and age are both predictors of pharmacokinetics of metformin. J Clin Pharmacol 35:1094–1102PubMedGoogle Scholar
  164. Seeliger E, Sendeski M, Rihal CS, Persson PB (2012) Contrast-induced kidney injury: mechanisms, risk factors, and prevention. Eur Heart J 33:2007–2015PubMedGoogle Scholar
  165. Sharma SK, Kini A (2005) Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials. Catheter Cardiovasc Interv 65:386–393PubMedGoogle Scholar
  166. Shaw JS, Wilmot RL, Kilpatrick ES (2007) Establishing pragmatic estimated GFR thresholds to guide metfromin prescribing. Diabet Med 24:1160–1163PubMedGoogle Scholar
  167. Sholy H, Zukerman R, Soni A, Nikolsky E (2012) Contrast induced nephropathy; an update on diagnosis, predictors, implications and preventive strategies. Minerva Med 103:465–486PubMedGoogle Scholar
  168. Slocum NK, Grossman PM, Moscucci M (2012) The changing definition of contrast-induced nephropathy and its clinical implications insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Am Heart J 163:829–834PubMedGoogle Scholar
  169. Solomon R (1998) Contrast medium-induced acute renal failure. Kidney Int 53:230–242PubMedGoogle Scholar
  170. Solomon R (2005) The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Kidney Int 68:2256–2263PubMedGoogle Scholar
  171. Solomon R, DuMouchel W (2006) Contrast media and nephropathy. Findings from systematic analysis and food and drug administration reports of adverse effects. Invest Radiol 41:651–660PubMedGoogle Scholar
  172. Solomon R, Werner C, Mann D et al (1994) Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416–1420PubMedGoogle Scholar
  173. Solomon R, Natarajan M, Doucet S et al (2007) The cardiac- angiography in renally impaired patients (CARE) study: a randomized, double blind trial of contrast-induced nephropathy (CIN) in high risk patients. Circulation 115:3189–3196PubMedGoogle Scholar
  174. Spargias K, Alexopoulos E, Kyrzopoulos S et al (2004) Ascorbic acid prevents contrast mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110:2837–2842PubMedGoogle Scholar
  175. Stacul F, van der Molen AJ, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety committee guidelines. Eur Radiol 21:2327–2541Google Scholar
  176. Stang M, Wysowski DK, Butler-Jones D (1999) Incidence of lactic acidosis in metformin users. Diabetes Care 22:925–927PubMedGoogle Scholar
  177. Stevens MA, McCullough PA, Tobin KJ et al (1999) A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy. Results of the P.R.I.N.C.E study. J Am Coll Cardiol 33:403–411PubMedGoogle Scholar
  178. Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med 354:2473–2483PubMedGoogle Scholar
  179. Stone GW, McCullough PA, Tumlin JA et al (2003) Contrast investigators. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 290:2284–2291PubMedGoogle Scholar
  180. Stratta P, Izzo C, Canavese C, Quaglia M (2013) Letter to the Editor re: are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections? Eur Radiol 23:1260–1263PubMedGoogle Scholar
  181. Suzuki H, Kanno Y, Sugahara S (2004) Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis 43:1056–1064PubMedGoogle Scholar
  182. Tamura A, Goto Y, Miyamoto K et al (2009) Efficacy of single bolus administration of sodium bicarbonate to prevent contrast induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure. Am J Cardiol 104:921–925PubMedGoogle Scholar
  183. Taylor AJ, Hotchkiss D, Morse RW, McCabe J (1998) PREPARED. Preparation for angiography in renal dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 114:1570–1574PubMedGoogle Scholar
  184. Tepel M, Giet MVD, Schwarzfeld C et al (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180–184PubMedGoogle Scholar
  185. Thomsen HS (1999) Contrast nephropathy. In: Thomsen HS, Muller RN, Mattrey RF (eds) Trends in contrast media. Springer, Berlin, pp 103–116Google Scholar
  186. Thomsen HS (2004) Gadolinium-based contrast media may be nephrotoxic even at approved doses (case report). Eur Radiol 15:749–754PubMedGoogle Scholar
  187. Thomsen HS, Golman K, Hemmingsen L et al (1993) Contrast medium induced nephropathy: animal experiments. Front Eur Radiol 9:83–108Google Scholar
  188. Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) In which patients should serum-creatinine be measured before contrast medium administration? Eur Radiol 15:749–756Google Scholar
  189. Thomsen HS, Morcos SK (2006) Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines. Eur Radiol 16:1835–1840PubMedGoogle Scholar
  190. Thomsen HS, Morcos SK (2009) Risk of contrast medium induced nephropathy in high risk patients undergoing MDCT—A pooled analysis of two randomized trials. Eur Radiol 19:891–897PubMedGoogle Scholar
  191. Thomsen HS, Morcos SK, Almen T et al (2010) Metformin and contrast media (letter). Radiology 256:672–673PubMedGoogle Scholar
  192. Thomsen HS, Morcos SK, Barrett BJ (2008a) Contrast induced nephropathy: the wheel has turned 360 degrees. Acta Radiol 49:646–657PubMedGoogle Scholar
  193. Thomsen HS, Morcos SK, Erley CM et al (2008b) The ACTIVE trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 43:170–178PubMedGoogle Scholar
  194. Thomsen HS, Morcos SK, ESUR Contrast Media Safety Committee (1999) Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent-diabetics after administration of contrast media. Eur Radiol 9:738–740Google Scholar
  195. Thomsen HS, Reimer P (2014) Intravascular contrast media for radiography, CT, MRI and Ultrasound, Chap 2. In: Adam A, Dixon AK, Gillard JH, Schaefer-Prokop C (eds) Grainger and Allison diagnostic radiology, 6th edn. Oxford: Churchill Livingstone (in press)Google Scholar
  196. Tippins RB, Torres WE, Baumgartner BR, Baumgarten DA (2000) Are screening serum creatinine levels necessary prior to outpatient CT examinations? Radiology 216:481–484PubMedGoogle Scholar
  197. Toprak O (2006) Angiotension converting emzymes inhibitors and contrast-induced nephropathy. Ren Fail 28:99–100Google Scholar
  198. Toprak O, Cirit M, Mayata S et al (2003) The effect of pre-procedural captopril on contrast media induced nephropathy who underwent coronary angiography. Anadolu Kardiyol Derg 3:98–103PubMedGoogle Scholar
  199. Trivedi HS, Moore H, Nasr S et al (2003) A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93:c29–c34PubMedGoogle Scholar
  200. Trivedi H, Foley WD (2010) Contrast-induced nephropathy after a second contrast exposure. Ren Fail 32:786–801Google Scholar
  201. Trivedi H, Nadella R, Szabo A (2010) Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials. Clin Nephrol 74:288–296PubMedGoogle Scholar
  202. Vaitkus PT, Brar C (2007) N-acetylcysteine in the prevention of contrast induced nephropathy: publication bias perpetuated by meta-analysis. Am Heart J 153:175–280Google Scholar
  203. Waikar SS, Bonventre JV (2009) Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 20:672–679PubMedGoogle Scholar
  204. Wang A, Holcslaw T, Bashore TM et al (2000) Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57:1675–1680PubMedGoogle Scholar
  205. Warren RE, Strachan MWJ, Wild S, McKnight JA (2007) Introducing glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin. Diabet Med 24:494–497PubMedGoogle Scholar
  206. Weinstein JM, Heyman S, Brezis M (1992) Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 62:413–415PubMedGoogle Scholar
  207. Weisberg L, Kurnik PB, Kurnik RC (1994) Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 45:259–265PubMedGoogle Scholar
  208. Weisbord SD, Palevsky PM (2008) Prevention of contrast induced nephropathy with volume expansion. Clin J Am Soc Nephrol 3:273–280PubMedGoogle Scholar
  209. Wessely R, Koppara T, Kastrati Aal (2008) Iso-osmolar vs low-osmolar contrast medium in patients with impaired renal function undergoing PCI—CONTRAST. Society for cardiovascular Angiography and Interventions Meeting (SCAI), Chicago, 1 April 2008Google Scholar
  210. Yamazaki H, Matsushita M, Inoue T et al (1997a) Renal cortical retention on delayed CT after angiography and contrast associated nephropathy. Br J Radiol 70:897–902PubMedGoogle Scholar
  211. Yamazaki H, Oi H, Matsushita M et al (1997b) Lack of correlation between gallbladder opacification in delayed CT and contrast-associated nephropathy. Eur Radiol 7:1328–1331PubMedGoogle Scholar
  212. Zagler A, Azadpour M, Mercado C, Hennekens CH (2005) N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J 151:140–145Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Henrik S. Thomsen
    • 1
  • Fulvio Stacul
    • 2
  • Judith A. W. Webb
    • 3
  1. 1.Department of Diagnostic RadiologyCopenhagen University Hospital HerlevHerlevDenmark
  2. 2.S. C. Radiologia Ospedale MaggioreAzienda Ospedaliero-Universitaria “Ospedali Riuniti” di TriesteTriesteItaly
  3. 3.Consultant Emeritus, Diagnostic Radiology DepartmentSt. Bartholomew’s Hospital, University of LondonLondonUK

Personalised recommendations